We are live on ! Find out more
EVGN icon

Evogene
EVGN

23 hedge funds and large institutions have $28.2M invested in Evogene in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

0.11% more ownership

Funds ownership: 35.21% → 35.32% (+0.11%)

4% less funds holding

Funds holding: 24 → 23 (-1)

8% less capital invested

Capital invested by funds: $30.6M → $28.2M (-$2.42M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$722K
2
AIM
ARK Investment Management
Florida
+$217K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$147K
4
UBS Group
UBS Group
Switzerland
+$48.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$35.7K

Top Sellers

Rank Fund Capital Flow
1
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$722K
2
Morgan Stanley
Morgan Stanley
New York
-$405K
3
SWM
Stockman Wealth Management
Montana
-$14.4K

EVGN Hedge Fund Activity: Q3 2018 in Review

23 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2018, worth a combined $28.2M — down 7.9% from $30.6M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EVGN and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 9 added.

The largest buyer was Goldman Sachs, adding an estimated $722K. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $722K.

  • 23 institutional investors held Evogene (EVGN) as of Q3 2018, down from 24 in Q2 2018.
  • Funds reported $28.2M of Evogene stock for Q3 2018, down 7.9% quarter-over-quarter.
  • 0 funds opened new Evogene positions in Q3 2018 and 1 closed out, a net change of -1 holder.
  • The largest Evogene buyer in Q3 2018 was Goldman Sachs, an estimated $722K added.
  • The largest Evogene seller in Q3 2018 was Canada Pension Plan Investment Board, an estimated $722K sold.

Based on aggregated 13F filings for Q3 2018.